90 related articles for article (PubMed ID: 2686016)
1. [Recent progress in the study of drug resistance in cancer cells].
Liu J; Xu B
Sheng Li Ke Xue Jin Zhan; 1989 Apr; 20(2):158-60. PubMed ID: 2686016
[No Abstract] [Full Text] [Related]
2. [Multidrug resistance (MDR)].
Wada M; Hasegawa S; Kohno K; Kuwano M
Gan To Kagaku Ryoho; 1994 Jun; 21(7):936-44. PubMed ID: 8002631
[TBL] [Abstract][Full Text] [Related]
3. [Is MDR 1 gene responsible for multidrug-resistance in cancer cells?].
Ueda K
Tanpakushitsu Kakusan Koso; 1988 Jul; 33(8):1287-99. PubMed ID: 3067257
[No Abstract] [Full Text] [Related]
4. [Recent progress in the study of the mechanism of resistance to DNA topoisomerase inhibitors].
Ishida R; Andoh T
Gan To Kagaku Ryoho; 1994 Jun; 21(7):952-61. PubMed ID: 8002633
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance and behavioural phenotype of cancer cells.
Bashir I; Sikora K; Foster CS
Cell Biol Int; 1993 Oct; 17(10):907-17. PubMed ID: 8287021
[TBL] [Abstract][Full Text] [Related]
6. [Resistance of cancer cells to antineoplastic agents. Can the efficiency of chemotherapy be predicted?].
Bénard J
Rev Prat; 1992 Feb; 42(3):318-9. PubMed ID: 1579821
[No Abstract] [Full Text] [Related]
7. Drug resistance modulation in the laboratory and the clinic.
Dalton WS
Semin Oncol; 1993 Feb; 20(1):64-9. PubMed ID: 8475411
[No Abstract] [Full Text] [Related]
8. [Multiple drug resistance of tumor cells: manifestations, genetic basis, clinical aspects].
Gudkov AV
Mol Gen Mikrobiol Virusol; 1987 Aug; (8):3-9. PubMed ID: 3317023
[TBL] [Abstract][Full Text] [Related]
9. Multiple drug resistance in cancer therapy.
Schneider E; Cowan KH
Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
[No Abstract] [Full Text] [Related]
10. [Antitumor drug resistance and therapeutic approaches to reverse resistance].
Tsuruo T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1715-25. PubMed ID: 3899014
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic approach against drug-resistant tumors and their biochemical nature].
Tsuruo T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1636-41. PubMed ID: 3592707
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance.
Fine RL; Chabner BA
Cancer Chemother Biol Response Modif; 1987; 9():81-92. PubMed ID: 2908588
[No Abstract] [Full Text] [Related]
13. Multidrug resistance.
Fine RL
Cancer Chemother Biol Response Modif; 1988; 10():73-84. PubMed ID: 2908587
[TBL] [Abstract][Full Text] [Related]
14. [Glutathione S transferases-pi].
Takahashi Y; Niitsu Y
Gan To Kagaku Ryoho; 1994 Jun; 21(7):945-51. PubMed ID: 8002632
[TBL] [Abstract][Full Text] [Related]
15. [Theory and actual attempts to establish an effective cancer chemotherapy].
Fujimoto S
Gan To Kagaku Ryoho; 1997 Feb; 24(4):501-10. PubMed ID: 9063491
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance in tumor cells.
Giulioni MA; Giorgi FC; Piga A; Gramazio A; Cellerino R
Rays; 1993; 18(3):330-9. PubMed ID: 7904371
[No Abstract] [Full Text] [Related]
17. Molecular biology of multidrug resistance in human cells.
Pastan IH; Gottesman MM
Important Adv Oncol; 1988; ():3-16. PubMed ID: 3042608
[No Abstract] [Full Text] [Related]
18. [Mechanism of action and resistance of antineoplastic agents].
Tanaka N
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
[TBL] [Abstract][Full Text] [Related]
19. Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines.
Vanhoefer U; Müller MR; Hilger RA; Lindtner B; Klaassen U; Schleucher N; Rustum YM; Seeber S; Harstrick A
Br J Cancer; 1999 Dec; 81(8):1304-10. PubMed ID: 10604726
[TBL] [Abstract][Full Text] [Related]
20. [General observation on drug resistance of cancer cells].
Inaba M
Gan To Kagaku Ryoho; 1982 Feb; 9(2):165-76. PubMed ID: 6764100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
